PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION SUITABLE FOR REDUCING OR PREVENTING INCREASED THROMBOCYTE-AGGREGATION CAPABILITY

The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min -diethoxy-benzyl)-6,7-diethoxy-3,4-dihydro-isoquinoline or (3 min ,4 min -diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophyllin-7-acetate or its monohydrate as active ing...

Full description

Saved in:
Bibliographic Details
Main Authors MARMAROSI,TAMASNE,HU, KAPUI,ZOLTAN,HU, HERMECZ,ISTVAN,HU, VASVARINE DEBRECZY,LELLE,HU, HORVATH,AGNES,HU, TARDOS,LASZLO,HU
Format Patent
LanguageEnglish
Published 30.11.1992
Edition5
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min -diethoxy-benzyl)-6,7-diethoxy-3,4-dihydro-isoquinoline or (3 min ,4 min -diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophyllin-7-acetate or its monohydrate as active ingredient for the manufacture of medicaments for use in the treatment or prevention of conditions resulting from increased thrombocyte - aggregatory activity as a consequence of decreased prostacyclin release.
Bibliography:Application Number: HU19910001198